AC Immune Statistics
Total Valuation
AC Immune has a market cap or net worth of $227.16 million. The enterprise value is $118.04 million.
| Market Cap | 227.16M |
| Enterprise Value | 118.04M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AC Immune has 99.20 million shares outstanding.
| Shares Outstanding | 99.20M |
| Owned by Insiders (%) | 41.87% |
| Owned by Institutions (%) | 30.23% |
| Float | 39.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.89 |
| Forward PS | 16.11 |
| PB Ratio | 1.29 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.22, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.22 |
| Quick Ratio | 8.73 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -307.09 |
Financial Efficiency
Return on equity (ROE) is -37.50% and return on invested capital (ROIC) is -32.67%.
| Return on Equity (ROE) | -37.50% |
| Return on Assets (ROA) | -33.30% |
| Return on Capital (ROIC) | -32.67% |
| Revenue Per Employee | $132,483 |
| Profits Per Employee | -$485,437 |
| Employee Count | 133 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AC Immune has paid $10,962 in taxes.
| Income Tax | 10,962 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.27% in the last 52 weeks. The beta is 1.01, so AC Immune's price volatility has been similar to the market average.
| Beta (1Y) | 1.01 |
| 52-Week Price Change | +19.27% |
| 50-Day Moving Average | 3.10 |
| 200-Day Moving Average | 3.22 |
| Relative Strength Index (RSI) | 27.93 |
| Average Volume (30 Days) | 186,117 |
Short Selling Information
| Short Interest | 509,355 |
| Short Previous Month | 560,589 |
| Short % of Shares Out | 0.96% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.10 |
Income Statement
In the last 12 months, AC Immune had revenue of $17.62 million and -$64.56 million in losses. Loss per share was -$0.70.
| Revenue | 17.62M |
| Gross Profit | 16.22M |
| Operating Income | -58.78M |
| Pretax Income | -59.44M |
| Net Income | -64.56M |
| EBITDA | -56.82M |
| EBIT | -59.24M |
| Loss Per Share | -$0.70 |
Balance Sheet
The company has $112.96 million in cash and $3.83 million in debt, giving a net cash position of $109.12 million or $1.10 per share.
| Cash & Cash Equivalents | 112.96M |
| Total Debt | 3.83M |
| Net Cash | 109.12M |
| Net Cash Per Share | $1.10 |
| Equity / Book Value | 176.09M |
| Book Value Per Share | 1.78 |
| Working Capital | 122.31M |
Cash Flow
In the last 12 months, operating cash flow was -$66.68 million and capital expenditures -$878,024, giving a free cash flow of -$67.55 million.
| Operating Cash Flow | -66.68M |
| Capital Expenditures | -878,024 |
| Free Cash Flow | -67.55M |
| FCF Per Share | -$0.80 |
Margins
Gross margin is 92.08%, with operating and profit margins of -333.60% and -366.41%.
| Gross Margin | 92.08% |
| Operating Margin | -333.60% |
| Pretax Margin | -337.32% |
| Profit Margin | -366.41% |
| EBITDA Margin | -322.45% |
| EBIT Margin | -336.23% |
| FCF Margin | -383.39% |
Dividends & Yields
AC Immune does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.30% |
| Shareholder Yield | -0.30% |
| Earnings Yield | -28.42% |
| FCF Yield | -29.74% |
Analyst Forecast
The average price target for AC Immune is $16.00, which is 598.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.00 |
| Price Target Difference | 598.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 85.89% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AC Immune has an Altman Z-Score of 3.03 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.03 |
| Piotroski F-Score | 2 |